David Davenport Md - MI Kalamazoo, Kalamazoo 49007

David Davenport Md entered the industry of Infectious Disease Specialists in 1992 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 621111, which describes it as a Infectious Disease Specialists. For further clarification, the SIC classifies this business under the code 8011 and described it as a Infectious Disease Specialists. The business provides service to the B2C market.

To acquire more information, please contact David Davenport by calling (269) 385-6394 during business hours. You can also write to the business’ Single Location at 252 East Lovell St, Kalamazoo, Michigan MI 49007. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: David Davenport Md
Representative: David Davenport
Place of Business: 252 East Lovell St, Kalamazoo, MI 49007
Contact Number: (269) 385-6394
Type of Service: Infectious Disease Specialists
SIC Number: 8011
NAICS Number: 621111
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 1992
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

David Davenport Md is a company operating from Kalamazoo, Michigan providing professional Infectious Disease Specialists and relevant B2C variables. It was founded in 1992 and registered with the SIC code 8011 as Infectious Disease Specialists, and with the NAICS code 621111 as Infectious Disease Specialists.

With a current employee count of 1 to 4, David Davenport Md has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative David Davenport at (269) 385-6394 for related queries, or to locate its Single Location using the coordinates .

The Single Location can also be found at the street address 252 East Lovell St in Kalamazoo, Michigan 49007 and can be engaged online through the company website at , the company Twitter , and Facebook page .